Association between red blood cell distribution width and mortality and severity among patients with COVID-19: A systematic review and meta-analysis.

ABSTRACT: Emerging evidence has underscored the potential usefulness of red blood cell distribution width (RDW) measurement in predicting the mortality and disease severity of COVID-19. This study aimed to assess the association of the plasma RDW levels with adverse prognosis in COVID-19 patients. A comprehensive literature search from inception to September 2020 was performed to harvest original studies reporting RDW on admission and clinical outcomes among patients hospitalized with COVID-19. RDW levels were compared between cases (patients who died or developed more severe symptoms) and controls (patients who survived or developed less severe symptoms). A total of 14,866 subjects from 10 studies were included in the meta-analysis. Higher levels of RDW were associated with adverse outcomes in COVI

SUBMITTER: Lee JJ 

PROVIDER: S-EPMC8014709 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature